ModerateCorticosteroids for local use (inhaled and nasal)×Selective serotonin reuptake inhibitors (SSRIs)
Updated · Methodology
Mechanism
Several pathways in the liver metabolise sertraline, including CYP3A4, CYP2C19 and CYP2B6. Sertraline does not inhibit CYP3A4 to a clinically significant extent (Besitran SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Beclometasone dipropionate is converted in the lungs and liver to 17-monopropionate and then to polar metabolites. It is less dependent on CYP3A than some other corticosteroids, and its SmPC advises caution only with strong CYP3A inhibitors such as ritonavir and cobicistat (Becloforte SmPC, AEMPS). The documents describe no pharmacokinetic link between the two drugs, and no document names this pair. What they share is an effect on the eye. Sertraline dilates the pupil and, especially in predisposed people, can narrow the anterior chamber angle, raise intraocular pressure and cause angle-closure glaucoma. Glaucoma, raised intraocular pressure and cataracts have been reported after long-term use of inhaled corticosteroids (Besitran and Becloforte SmPCs, AEMPS; Zoloft and Qvar RediHaler labels, US Food and Drug Administration, FDA).
Symptoms
The documents describe no symptoms specific to this combination. Angle-closure glaucoma presents with eye pain, changes in vision, or swelling or redness in or around the eye (Zoloft label, US Food and Drug Administration, FDA). In people using corticosteroids, blurred vision or other visual disturbances may be a sign of cataracts, glaucoma or central serous chorioretinopathy (Becloforte SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Sertraline itself commonly causes nausea, diarrhoea, dry mouth, insomnia or drowsiness, dizziness and headache. Beclometasone causes oral and throat candidiasis, hoarseness and throat irritation (Besitran and Becloforte SmPCs, AEMPS).
Management
The combination is not contraindicated, and the documents give no measures specific to this pair. The warnings for both drugs mention glaucoma, however, so the combination requires caution (Besitran and Becloforte SmPCs, Spanish Agency of Medicines and Medical Devices, AEMPS; Zoloft and Qvar RediHaler labels, US Food and Drug Administration, FDA). Sertraline is taken with caution in angle-closure glaucoma or a history of glaucoma (Besitran SmPC, AEMPS). The US label says to avoid antidepressants, including sertraline, in people with untreated anatomically narrow angles (Zoloft label, FDA). If a person using beclometasone develops blurred vision or other visual disturbances, they are referred to an ophthalmologist (Becloforte SmPC, AEMPS). In people with a change in vision or a history of raised intraocular pressure, blurred vision, glaucoma or cataracts, the eyes are closely monitored while beclometasone is used (Qvar RediHaler label, FDA). The inhaled corticosteroid dose is kept at the lowest level that maintains asthma control (Becloforte SmPC, AEMPS). Doses are not changed because of the combination itself. Sertraline does not inhibit CYP3A4 to a clinically significant extent, and the caution for beclometasone concerns only strong CYP3A inhibitors (Besitran and Becloforte SmPCs, AEMPS).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- FDA: Zoloft (sertraline hydrochloride) prescribing information (2023)– FDA label, Viatris Specialty LLC, DailyMed setid fda754f6-d0f3-4dce-a17a-927d64f912f7, revised 08/2023, sections 4, 5.2 and 7.1
- AEMPS: Ficha técnica: Sertralina, Besitran 50 mg (nº registro 59717), secciones 4.4 y 4.5 (2025)– AEMPS, CIMA, nº registro 59717, revisión 08/2025, secciones 4.4 y 4.5
- AEMPS: Ficha técnica BECLOFORTE 250 microgramos/inhalación SOLUCION PARA INHALACION EN ENVASE A PRESION (2022)– AEMPS. Ficha técnica BECLOFORTE 250 microgramos/inhalación SOLUCION PARA INHALACION EN ENVASE A PRESION (revisión 2022). CIMA, https://cima.aemps.es/cima/dochtml/ft/59377/FT_59377.html
- FDA: QVAR RediHaler (beclomethasone dipropionate HFA) prescribing information (2025)– FDA, DailyMed setid cada897a-264e-450d-ae00-36e7fe747080 (Teva Respiratory), version 17, revised 09/2025, sections 5.9, 5.10 and 12.3